Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Visa
V
|
+$2.17B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.84B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 4 |
Linde
LIN
|
+$743M |
| 5 |
DuPont de Nemours
DD
|
+$592M |
Top Sells
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.5B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$311M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$281M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
IAC Inc
IAC
|
+$239M |
Sector Composition
| 1 | Technology | 17.81% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.06% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Enterprise Financial Services Corp
EFSC
$2.21B
| $300K | ﹤0.01% |
10,994
-2,688
| -20% | -$73.3K |
|
|
TBNK
2502
DELISTED
Territorial Bancorp Inc.
TBNK
| $300K | ﹤0.01% |
14,792
+2,003
| +16% | +$40.6K |
|
|
PCSB
2503
DELISTED
PCSB Financial Corporation
PCSB
| $299K | ﹤0.01% |
24,821
+1,173
| +5% | +$14.1K |
|
2504
MasterCraft Boat Holdings
MCFT
$370M
| $298K | ﹤0.01% |
17,105
-16,302
| -49% | -$284K |
|
|
NEWR
2505
DELISTED
New Relic, Inc.
NEWR
| $296K | ﹤0.01% |
5,254
-10,509
| -67% | -$592K |
|
|
HIO
2506
Western Asset High Income Opportunity Fund
HIO
$378M
| $294K | ﹤0.01% |
55,692
+5,102
| +10% | +$26.9K |
|
|
TMX
2507
DELISTED
Terminix Global Holdings, Inc.
TMX
| $294K | ﹤0.01% |
7,371
-8,788
| -54% | -$351K |
|
|
CRC
2508
DELISTED
California Resources Corporation
CRC
| $293K | ﹤0.01% |
249,088
+61,216
| +33% | +$72K |
|
2509
AnaptysBio
ANAB
$564M
| $292K | ﹤0.01% |
19,840
-4,052
| -17% | -$59.6K |
|
2510
Five Point Holdings
FPH
$429M
| $292K | ﹤0.01% |
70,087
| – | – |
|
|
SLCA
2511
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $292K | ﹤0.01% |
97,202
+1,617
| +2% | +$4.86K |
|
|
PRVB
2512
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $292K | ﹤0.01% |
+22,744
| New | +$292K |
|
2513
Tilly's
TLYS
$60.9M
| $291K | ﹤0.01% |
48,243
+28,393
| +143% | +$171K |
|
|
TARO
2514
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $291K | ﹤0.01% |
5,300
-2,800
| -35% | -$154K |
|
2515
i3 Verticals
IIIV
$735M
| $290K | ﹤0.01% |
11,500
-13,117
| -53% | -$331K |
|
2516
Codexis
CDXS
$220M
| $289K | ﹤0.01% |
24,600
-4,892
| -17% | -$57.5K |
|
2517
Seneca Foods Class A
SENEA
$739M
| $287K | ﹤0.01% |
8,039
+1,773
| +28% | +$63.3K |
|
2518
Cue Biopharma
CUE
$56.9M
| $286K | ﹤0.01% |
19,028
+3,481
| +22% | +$52.3K |
|
2519
Greenlight Captial
GLRE
$429M
| $285K | ﹤0.01% |
42,297
-7,799
| -16% | -$52.6K |
|
2520
Webster Financial
WBS
$10.1B
| $285K | ﹤0.01% |
10,766
+619
| +6% | +$16.4K |
|
|
BHR
2521
Braemar Hotels & Resorts
BHR
$206M
| $284K | ﹤0.01% |
113,557
-30,694
| -21% | -$76.8K |
|
2522
Protagonist Therapeutics
PTGX
$3.63B
| $284K | ﹤0.01% |
14,527
+1,936
| +15% | +$37.8K |
|
2523
Argan
AGX
$3.3B
| $283K | ﹤0.01% |
6,752
-2,302
| -25% | -$96.5K |
|
2524
Newmark Group
NMRK
$3.39B
| $282K | ﹤0.01% |
65,409
-16,558
| -20% | -$71.4K |
|
|
TVRD
2525
Tvardi Therapeutics, Inc. Common Stock
TVRD
$317M
| $282K | ﹤0.01% |
614
-257
| -30% | -$118K |
|